Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to Previous Treatments

NCT07517315 · clinicaltrials.gov ↗

TEMPORARILY_NOT_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

CML, Relapsed
CML, Refractory

Interventions

DRUG: K0706

Sponsor

Sun Pharma Advanced Research Company Limited